Zobrazeno 1 - 10
of 193
pro vyhledávání: '"Osinga, K."'
Publikováno v:
Nucleic Acids Research; 2/15/1984, Vol. 12 Issue 4, p1889-1900, 12p
Publikováno v:
Nucleic Acids Research; 12/15/1982, Vol. 10 Issue 24, p7993-8006, 14p
Autor:
Michels, Paul A.M.1, Marchand, Martine1, Kohl, Linda1, Allert, Sylvie1, Wierenga, Rik K.2, Opperdoes, Fred R.1
Publikováno v:
European Journal of Biochemistry. 6/1/91, Vol. 198 Issue 2, p421-428. 8p.
Autor:
Wierenga, R. K., Swinkels, B., Michels, P. A. M., Osinga, K., Misset, O., van Beeumen, J., Gibson, W. C., Postma, J. P. M., Borst, P., Opperdoes, F. R., Hol, W. G. J.
Publikováno v:
Europe PubMed Central
Scopus-Elsevier
The EMBO journal, Vol. 6, no. 1, p. 215-21 (1987)
EMBO Journal, 6(1), 215-221. Wiley
Scopus-Elsevier
The EMBO journal, Vol. 6, no. 1, p. 215-21 (1987)
EMBO Journal, 6(1), 215-221. Wiley
In Trypanosoma brucei, a major pathogenic protozoan parasite of Central Africa, a number of glycolytic enzymes present in the cytosol of other organisms are uniquely segregated in a microbody-like organelle, the glycosome, which they are believed to
Publikováno v:
Folia Microbiologica; Nov1994, Vol. 39 Issue 6, p524-526, 3p
Autor:
Mansour, Khalefa Ali1 khalefa.mansour@qu.edu.iq, Naser, Hassan Hachim1 hassan.naser@qu.edu.iq, Hussain, Muthanna Hadi1 muthanna.hussain@qu.edu.iq
Publikováno v:
Veterinary World. Sep2018, Vol. 11 Issue 9, p1210-1213. 4p.
Autor:
Koster CC; Department of Biotechnology, Delft University of Technology, Delft, The Netherlands., Kleefeldt AA; Department of Biotechnology, Delft University of Technology, Delft, The Netherlands., van den Broek M; Department of Biotechnology, Delft University of Technology, Delft, The Netherlands., Luttik M; Department of Biotechnology, Delft University of Technology, Delft, The Netherlands., Daran JM; Department of Biotechnology, Delft University of Technology, Delft, The Netherlands., Daran-Lapujade P; Department of Biotechnology, Delft University of Technology, Delft, The Netherlands.
Publikováno v:
Yeast (Chichester, England) [Yeast] 2024 Apr; Vol. 41 (4), pp. 256-278. Date of Electronic Publication: 2023 Aug 29.
Autor:
Ngo LH; RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Bert AG; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Dredge BK; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; Adelaide Centre for Epigenetics, School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.; South Australian immunoGENomics Cancer Institute (SAiGENCI), Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia., Williams T; RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Murphy V; Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Li W; RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Department of Pharmacology, Joint Laboratory of Guangdong-Hong Kong Universities for Vascular Homeostasis and Diseases, School of Medicine and Institute for Biological Electron Microscopy, Southern University of Science and Technology, Shenzhen, China., Hamilton WB; RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Carey KT; RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Toubia J; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Pillman KA; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia.; Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia., Liu D; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia., Desogus J; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.; University of Basel, Basel, Switzerland., Chao JA; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland., Deans AJ; Genome Stability Unit, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia., Goodall GJ; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, South Australia, Australia. greg.goodall@unisa.edu.au.; Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, Australia. greg.goodall@unisa.edu.au.; Department of Medicine, University of Adelaide, Adelaide, South Australia, Australia. greg.goodall@unisa.edu.au., Wickramasinghe VO; RNA Biology and Cancer Laboratory, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia. vi.wickramasinghe@petermac.org.; Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, Victoria, Australia. vi.wickramasinghe@petermac.org.
Publikováno v:
Nature [Nature] 2024 Mar; Vol. 627 (8002), pp. 212-220. Date of Electronic Publication: 2024 Feb 14.
Publikováno v:
European Physical Journal Plus; Jul2022, Vol. 137 Issue 7, p1-9, 9p
Publikováno v:
Frontiers in Microbiology; 3/21/2022, Vol. 13, p1-22, 22p